Risk  ||| S:0 E:5 ||| NN
factors  ||| S:5 E:13 ||| NNS
and  ||| S:13 E:17 ||| CC
prognosis  ||| S:17 E:27 ||| NN
of  ||| S:27 E:30 ||| IN
hypotension  ||| S:30 E:42 ||| NN
in  ||| S:42 E:45 ||| IN
postoperative  ||| S:45 E:59 ||| JJ
sedation  ||| S:59 E:68 ||| JJ
patients  ||| S:68 E:77 ||| NNS
To  ||| S:77 E:80 ||| TO
explore  ||| S:80 E:88 ||| VB
the  ||| S:88 E:92 ||| DT
risk  ||| S:92 E:97 ||| NN
factors  ||| S:97 E:105 ||| NNS
and  ||| S:105 E:109 ||| CC
prognosis  ||| S:109 E:119 ||| NN
of  ||| S:119 E:122 ||| IN
hypotension  ||| S:122 E:134 ||| NN
in  ||| S:134 E:137 ||| IN
postoperative  ||| S:137 E:151 ||| JJ
sedation  ||| S:151 E:160 ||| JJ
patients ||| S:160 E:168 ||| NNS
.  ||| S:168 E:170 ||| .
A  ||| S:170 E:172 ||| DT
total  ||| S:172 E:178 ||| NN
of  ||| S:178 E:181 ||| IN
175  ||| S:181 E:185 ||| CD
patients  ||| S:185 E:194 ||| NNS
with  ||| S:194 E:199 ||| IN
postoperative  ||| S:199 E:213 ||| JJ
sedation  ||| S:213 E:222 ||| NN
at  ||| S:222 E:225 ||| IN
our  ||| S:225 E:229 ||| PRP$
department  ||| S:229 E:240 ||| NN
from  ||| S:240 E:245 ||| IN
May  ||| S:245 E:249 ||| NNP
2013  ||| S:249 E:254 ||| CD
to  ||| S:254 E:257 ||| TO
March  ||| S:257 E:263 ||| NNP
2014  ||| S:263 E:268 ||| CD
were  ||| S:268 E:273 ||| VBD
retrospectively  ||| S:273 E:289 ||| VBN
reviewed ||| S:289 E:297 ||| VBN
.  ||| S:297 E:299 ||| .
Patients  ||| S:299 E:308 ||| NNS
with  ||| S:308 E:313 ||| IN
age  ||| S:313 E:317 ||| NN
< ||| S:317 E:318 ||| SYM
18  ||| S:318 E:321 ||| CD
years ||| S:321 E:326 ||| NNS
,  ||| S:326 E:328 ||| ,
cardiac  ||| S:328 E:336 ||| JJ
surgery ||| S:336 E:343 ||| NN
,  ||| S:343 E:345 ||| ,
pheochromocytoma  ||| S:345 E:362 ||| JJ
surgery ||| S:362 E:369 ||| NN
,  ||| S:369 E:371 ||| ,
hemorrhagic  ||| S:371 E:383 ||| JJ
shock ||| S:383 E:388 ||| NN
,  ||| S:388 E:390 ||| ,
septic  ||| S:390 E:397 ||| JJ
shock  ||| S:397 E:403 ||| NN
or  ||| S:403 E:406 ||| CC
cardiogenic  ||| S:406 E:418 ||| JJ
shock  ||| S:418 E:424 ||| NN
were  ||| S:424 E:429 ||| VBD
excluded ||| S:429 E:437 ||| VBN
.  ||| S:437 E:439 ||| .
APACHE  ||| S:439 E:446 ||| NNP
II ||| S:446 E:448 ||| NNP
,  ||| S:448 E:450 ||| ,
dosage  ||| S:450 E:457 ||| NN
and  ||| S:457 E:461 ||| CC
duration  ||| S:461 E:470 ||| NN
of  ||| S:470 E:473 ||| IN
sedative  ||| S:473 E:482 ||| JJ
drug ||| S:482 E:486 ||| NN
,  ||| S:486 E:488 ||| ,
mean  ||| S:488 E:493 ||| VBP
arterial  ||| S:493 E:502 ||| JJ
pressure  ||| S:502 E:511 ||| NN
at  ||| S:511 E:514 ||| IN
baseline  ||| S:514 E:523 ||| NN
and  ||| S:523 E:527 ||| CC
after  ||| S:527 E:533 ||| IN
sedation ||| S:533 E:541 ||| NN
,  ||| S:541 E:543 ||| ,
central  ||| S:543 E:551 ||| JJ
venous  ||| S:551 E:558 ||| JJ
pressure ||| S:558 E:566 ||| NN
,  ||| S:566 E:568 ||| ,
fluid  ||| S:568 E:574 ||| JJ
balance ||| S:574 E:581 ||| NN
,  ||| S:581 E:583 ||| ,
dosage  ||| S:583 E:590 ||| NN
and  ||| S:590 E:594 ||| CC
duration  ||| S:594 E:603 ||| NN
of  ||| S:603 E:606 ||| IN
norepinephrine ||| S:606 E:620 ||| NN
,  ||| S:620 E:622 ||| ,
endotracheal  ||| S:622 E:635 ||| JJ
intubation  ||| S:635 E:646 ||| JJ
time  ||| S:646 E:651 ||| NN
and  ||| S:651 E:655 ||| CC
length  ||| S:655 E:662 ||| NN
of  ||| S:662 E:665 ||| IN
intensive  ||| S:665 E:675 ||| JJ
care  ||| S:675 E:680 ||| NN
unit  ||| S:680 E:685 ||| NN
( ||| S:685 E:686 ||| -LRB-
ICU ||| S:686 E:689 ||| NNP
)  ||| S:689 E:691 ||| -RRB-
stay  ||| S:691 E:696 ||| NN
were  ||| S:696 E:701 ||| VBD
recorded ||| S:701 E:709 ||| VBN
.  ||| S:709 E:711 ||| .
Blood  ||| S:711 E:717 ||| NN
pressures  ||| S:717 E:727 ||| NNS
decreased  ||| S:727 E:737 ||| VBD
significantly  ||| S:737 E:751 ||| RB
after  ||| S:751 E:757 ||| IN
administration  ||| S:757 E:772 ||| NN
of  ||| S:772 E:775 ||| IN
sedation  ||| S:775 E:784 ||| NNS
( ||| S:784 E:785 ||| -LRB-
77.2  ||| S:785 E:790 ||| CD
±  ||| S:790 E:792 ||| CD
11.2  ||| S:792 E:797 ||| CD
vs  ||| S:797 E:800 ||| CD
82.6  ||| S:800 E:805 ||| CD
±  ||| S:805 E:807 ||| CD
9.3  ||| S:807 E:811 ||| CD
mmHg ||| S:811 E:815 ||| NN
,  ||| S:815 E:817 ||| ,
P  ||| S:817 E:819 ||| NN
=  ||| S:819 E:821 ||| SYM
0.000 ||| S:821 E:826 ||| CD
) ||| S:826 E:827 ||| -RRB-
.  ||| S:827 E:829 ||| .
Compared  ||| S:829 E:838 ||| VBN
to  ||| S:838 E:841 ||| TO
those  ||| S:841 E:847 ||| DT
with  ||| S:847 E:852 ||| IN
lower  ||| S:852 E:858 ||| JJR
disease  ||| S:858 E:866 ||| NN
severity  ||| S:866 E:875 ||| NN
( ||| S:875 E:876 ||| -LRB-
APACHEII  ||| S:876 E:885 ||| NNP
≤  ||| S:885 E:887 ||| CD
10 ||| S:887 E:889 ||| CD
) ||| S:889 E:890 ||| -RRB-
,  ||| S:890 E:892 ||| ,
the  ||| S:892 E:896 ||| DT
patients  ||| S:896 E:905 ||| NNS
with  ||| S:905 E:910 ||| IN
APACHEII. ||| S:910 E:919 ||| CD
> ||| S:919 E:920 ||| CD
10  ||| S:920 E:923 ||| CD
required  ||| S:923 E:932 ||| VBN
higher  ||| S:932 E:939 ||| RBR
norepinephrine  ||| S:939 E:954 ||| JJ
dosage  ||| S:954 E:961 ||| NN
and  ||| S:961 E:965 ||| CC
longer  ||| S:965 E:972 ||| JJR
time  ||| S:972 E:977 ||| NN
of  ||| S:977 E:980 ||| IN
infusion ||| S:980 E:988 ||| NN
.  ||| S:988 E:990 ||| .
A  ||| S:990 E:992 ||| DT
longer  ||| S:992 E:999 ||| JJR
time  ||| S:999 E:1004 ||| NN
of  ||| S:1004 E:1007 ||| IN
norepinephrine  ||| S:1007 E:1022 ||| JJ
infusion  ||| S:1022 E:1031 ||| NN
was  ||| S:1031 E:1035 ||| VBD
needed  ||| S:1035 E:1042 ||| VBN
for  ||| S:1042 E:1046 ||| IN
patients  ||| S:1046 E:1055 ||| NNS
with  ||| S:1055 E:1060 ||| IN
coronary  ||| S:1060 E:1069 ||| JJ
heart  ||| S:1069 E:1075 ||| NN
disease ||| S:1075 E:1082 ||| NN
.  ||| S:1082 E:1084 ||| .
Patients  ||| S:1084 E:1093 ||| NNS
undergoing  ||| S:1093 E:1104 ||| VBG
thoracic ||| S:1104 E:1112 ||| NN
,  ||| S:1112 E:1114 ||| ,
abdominal  ||| S:1114 E:1124 ||| NN
or  ||| S:1124 E:1127 ||| CC
pelvic  ||| S:1127 E:1134 ||| JJ
surgery ||| S:1134 E:1141 ||| NN
,  ||| S:1141 E:1143 ||| ,
or  ||| S:1143 E:1146 ||| CC
those  ||| S:1146 E:1152 ||| DT
with  ||| S:1152 E:1157 ||| IN
hepatic  ||| S:1157 E:1165 ||| JJ
dysfunction  ||| S:1165 E:1177 ||| NN
had  ||| S:1177 E:1181 ||| VBD
a  ||| S:1181 E:1183 ||| DT
higher  ||| S:1183 E:1190 ||| JJR
norepinephrine  ||| S:1190 E:1205 ||| JJ
dosage ||| S:1205 E:1211 ||| NN
.  ||| S:1211 E:1213 ||| .
Decrement  ||| S:1213 E:1223 ||| NNP
of  ||| S:1223 E:1226 ||| IN
blood  ||| S:1226 E:1232 ||| NN
pressure  ||| S:1232 E:1241 ||| NN
and  ||| S:1241 E:1245 ||| CC
norepinephrine  ||| S:1245 E:1260 ||| JJ
duration  ||| S:1260 E:1269 ||| NN
were  ||| S:1269 E:1274 ||| VBD
independent  ||| S:1274 E:1286 ||| JJ
risk  ||| S:1286 E:1291 ||| NN
factors  ||| S:1291 E:1299 ||| NNS
of  ||| S:1299 E:1302 ||| IN
endotracheal  ||| S:1302 E:1315 ||| JJ
intubation  ||| S:1315 E:1326 ||| JJ
time ||| S:1326 E:1330 ||| NN
.  ||| S:1330 E:1332 ||| .
And  ||| S:1332 E:1336 ||| CC
dosage  ||| S:1336 E:1343 ||| NN
and  ||| S:1343 E:1347 ||| CC
duration  ||| S:1347 E:1356 ||| NN
of  ||| S:1356 E:1359 ||| IN
norepinephrine  ||| S:1359 E:1374 ||| NN
were  ||| S:1374 E:1379 ||| VBD
independent  ||| S:1379 E:1391 ||| JJ
risk  ||| S:1391 E:1396 ||| NN
factors  ||| S:1396 E:1404 ||| NNS
of  ||| S:1404 E:1407 ||| IN
ICU  ||| S:1407 E:1411 ||| NNP
time ||| S:1411 E:1415 ||| NN
.  ||| S:1415 E:1417 ||| .
Disease  ||| S:1417 E:1425 ||| NN
severity ||| S:1425 E:1433 ||| NN
,  ||| S:1433 E:1435 ||| ,
past  ||| S:1435 E:1440 ||| JJ
history  ||| S:1440 E:1448 ||| NN
of  ||| S:1448 E:1451 ||| IN
heart  ||| S:1451 E:1457 ||| NN
disease ||| S:1457 E:1464 ||| NN
,  ||| S:1464 E:1466 ||| ,
surgical  ||| S:1466 E:1475 ||| JJ
site  ||| S:1475 E:1480 ||| NN
and  ||| S:1480 E:1484 ||| CC
liver  ||| S:1484 E:1490 ||| JJ
function  ||| S:1490 E:1499 ||| NNS
are  ||| S:1499 E:1503 ||| VBP
risk  ||| S:1503 E:1508 ||| NN
factors  ||| S:1508 E:1516 ||| NNS
of  ||| S:1516 E:1519 ||| IN
hypotension  ||| S:1519 E:1531 ||| NN
in  ||| S:1531 E:1534 ||| IN
postoperative  ||| S:1534 E:1548 ||| JJ
sedation  ||| S:1548 E:1557 ||| JJ
patients ||| S:1557 E:1565 ||| NNS
.  ||| S:1565 E:1567 ||| .
It  ||| S:1567 E:1570 ||| PRP
is  ||| S:1570 E:1573 ||| VBZ
important  ||| S:1573 E:1583 ||| JJ
to  ||| S:1583 E:1586 ||| TO
pay  ||| S:1586 E:1590 ||| VB
attention  ||| S:1590 E:1600 ||| NN
to  ||| S:1600 E:1603 ||| TO
dosage  ||| S:1603 E:1610 ||| VB
and  ||| S:1610 E:1614 ||| CC
administrative  ||| S:1614 E:1629 ||| JJ
route  ||| S:1629 E:1635 ||| NN
of  ||| S:1635 E:1638 ||| IN
sedative  ||| S:1638 E:1647 ||| JJ
drug ||| S:1647 E:1651 ||| NN
.  ||| S:1651 E:1653 ||| .
Norepinephrine  ||| S:1653 E:1668 ||| JJ
duration  ||| S:1668 E:1677 ||| NN
after  ||| S:1677 E:1683 ||| IN
sedation  ||| S:1683 E:1692 ||| NN
is  ||| S:1692 E:1695 ||| VBZ
an  ||| S:1695 E:1698 ||| DT
independent  ||| S:1698 E:1710 ||| JJ
risk  ||| S:1710 E:1715 ||| NN
factor  ||| S:1715 E:1722 ||| NN
of  ||| S:1722 E:1725 ||| IN
endotracheal  ||| S:1725 E:1738 ||| JJ
intubation  ||| S:1738 E:1749 ||| JJ
time  ||| S:1749 E:1754 ||| NN
and  ||| S:1754 E:1758 ||| CC
ICU  ||| S:1758 E:1762 ||| NNP
time ||| S:1762 E:1766 ||| NN
.  ||| S:1766 E:1768 ||| .
